For laboratory research use only. Not for human or veterinary use.Lab research use only. Not for human or animal use.
Copper-peptide and multi-peptide research materials — including GHK-Cu and GLOW — studied in copper-binding, collagen and extracellular-matrix assays and supplied to laboratories and researchers. Every vial is independently lab-tested before release, with published certificates listed by product and strength in the COA library, stocked in Australia and dispatched the same business day when ordered before 12pm Sydney time. For in vitro research purposes only.
Copper peptide research covers GHK-Cu, a copper-bound tripeptide, and the multi-peptide blends built around it, studied in copper-binding, collagen and extracellular-matrix laboratory work. This category holds GHK-Cu itself and two blends: GLOW, which adds BPC-157 and TB-500, and KLOW, which adds KPV as well. All are freeze-dried research materials, for in vitro use.
It is freeze-dried copper peptide in a sealed glass research vial, not a cosmetic serum or skincare cream, shipped Australia-wide. Its copper is bound inside a three-amino-acid chain of glycine, L-histidine and L-lysine. Research compares its copper affinity with the copper transport site on albumin. In vitro research purposes only.
A published batch certificate confirms the identity and measured amount of all three peptides. GHK-Cu, a copper-carrying tripeptide, is most of it by mass. BPC-157 is a fifteen-residue chain studied against VEGFR2 and nitric oxide signalling in assays; TB-500 is the seven-residue actin-binding motif of thymosin beta-4. ARP ships to every state and territory, and GLOW is a trade name, not a specification. In vitro research purposes only.
KLOW is a four-peptide blend, the blend buyers describe as GLOW plus KPV, in one lyophilised vial. GHK-Cu, BPC-157, TB-500 and KPV are dried together into a single cake at a nominal ~50/10/10/10 mg split rather than an assayed one. Its research context spans cell migration and inflammatory signalling, with GHK-Cu carrying most of the mass. Post reaches every Australian state and territory. In vitro research purposes only.
Choose by whether a single compound or a prepared blend suits the protocol. GHK-Cu is one copper-binding tripeptide, studied in copper-binding and extracellular-matrix research; GLOW and KLOW are multi-peptide blends whose components are itemised on their own pages. Each is listed in one strength, and the three strengths are far apart.